Related Articles
FDA Eliminates Clozapine REMS Program: What This Means for Patients and Prescribers
In a major regulatory update, the U.S. Food and Drug Administration (FDA) has announced the discontinuation of the Risk Evaluation and Mitigation Strategy (REMS) program…
First Two-Monthly Long-Acting Injectable: Abilify Asimtufii®
On April 27, 2023: Otsuka America Pharmaceutical, Inc. (Otsuka) and Lundbeck announced that FDA has approved the New Drug Application for Abilify Asimtufii. This post…
Top 10 Viewed Posts in 2022
As we approach the end of 2022, I want to wish you all a safe and Happy New Year. Hope this new year makes all…
Comparing Long-Acting Methylphenidate: Concerta vs Jornay PM vs Adhansia XR
Attention-deficit/hyperactivity disorder (ADHD) is a common and impairing disorder affecting children, adolescents, and adults. Stimulant class of medications are considered first-line treatment for ADHD, including…
Top 5 Psychiatry Articles Discussed on PEF
Happy New Year to all PEF Followers I want to thank you all for following Psychiatry Education Forum and giving me the encouragement to continue…